...
首页> 外文期刊>International journal of gynecological pathology: Official journal of the International Society of Gynecological Pathologists >Ki-67 Labeling Index as an Adjunct in the Diagnosis of Serous Tubal Intraepithelial Carcinoma
【24h】

Ki-67 Labeling Index as an Adjunct in the Diagnosis of Serous Tubal Intraepithelial Carcinoma

机译:Ki-67标记指数作为浆液性输卵管上皮内癌的辅助诊断

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

There is mounting evidence that serous tubal intraepithelial carcinoma (STIC) may be the immediate precursor of ovarian high-grade serous carcinoma (HGSC) but the criteria for its diagnosis are not well established as highlighted in a recent study showing that interobserver reproducibility, even among expert gynecologic pathologists, was moderate at best. Given the clinical significance of a diagnosis of STIC in a patient who has no other evidence of ovarian carcinoma, this is a serious issue that we felt needed to be addressed. Although it is not clear, at this time, whether such a patient should or should not be treated, the importance of an accurate and reproducible diagnosis of precursors of ovarian carcinoma cannot be underestimated. We hypothesized that an elevated Ki-67 labeling index may aid the diagnosis of STIC. Accordingly, we compared the Ki-67 index of STIC and HGSC to normal fallopian tube epithelium (FTE) in the same patients and to a control group of patients without carcinoma, matched for age. A total of 41 STICs were analyzed, of which 35 were associated with a concurrent HGSC. In FTE, immunoreactivity for Ki-67 was restricted to a few scattered cells (mean 2.0%). No statistically significant difference was found between patients with and without HGSC (P>0.05). However, both STICs and HGSC had significantly higher Ki-67 indices than normal FTE (P<0.0001). STICs uniformly had an elevated Ki-67 labeling index that ranged from 11.7% to 71.1% (average 35.6%). There was no correlation of the Ki-67 labeling index in the STICs and the associated HGSC, as the labeling index was lower in STIC in 18/35 (51.4%) whereas it was higher in 17/35 (48.6%) (P=0.86). In conclusion, the findings in this study indicate that compared with FTE, STICs have a significantly higher Ki-67 index similar to HGSC. Accordingly, the Ki-67 index can aid the diagnosis of intraepithelial tubal proliferations suspicious for STIC. Therefore, we propose that a Ki-67 index of 10% is a useful diagnostic tool to distinguish STICs from normal FTE.
机译:越来越多的证据表明浆液性输卵管上皮内癌(STIC)可能是卵巢高级浆液性癌(HGSC)的直接前体,但其诊断标准尚不完善,如最近的一项研究表明,观察者间的可重复性妇科病理学家专家最多为中度。鉴于在没有其他卵巢癌证据的患者中诊断STIC的临床意义,这是一个严重的问题,我们认为需要解决。尽管目前尚不清楚,是否应该治疗此类患者,但不能低估准确和可重复诊断卵巢癌前体的重要性。我们假设Ki-67标记指数升高可能有助于STIC的诊断。因此,我们将STIC和HGSC的Ki-67指数与相同患者的正常输卵管上皮(FTE)以及与年龄匹配的无癌的对照组患者进行了比较。总共分析了41个STIC,其中35个与并发HGSC相关。在FTE中,针对Ki-67的免疫反应仅限于少数散在的细胞(平均2.0%)。有和没有HGSC的患者之间无统计学差异(P> 0.05)。但是,STIC和HGSC的Ki-67指数均显着高于正常FTE(P <0.0001)。 STIC均匀地具有升高的Ki-67标记指数,范围从11.7%至71.1%(平均35.6%)。 STIC中的Ki-67标记指数与相关的HGSC没有相关性,因为STIC中的标记指数在18/35中较低(51.4%),而在17/35中则较高(48.6%)(P = 0.86)。总之,这项研究的结果表明,与FTE相比,STIC与HGSC相比具有显着更高的Ki-67指数。因此,Ki-67指数有助于诊断可疑STIC的上皮内输卵管增生。因此,我们建议Ki-67指数为10%是区分STIC和正常FTE的有用诊断工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号